News
AstraZeneca CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...
On a per-share basis, the Cambridge, Britain-based company said it had profit of 93 cents. Earnings, adjusted for non-recurring costs, came to $1.24 per share. The results topped Wall Street ...
AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said ...
11h
Tuko on MSNAstraZeneca moves some production to US amid tariff threatLondon: British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production ...
15h
DPA International on MSNAstraZeneca's Q1 profit rises on strong sales; outlook reaffirmedBritish pharmaceutical giant AstraZeneca reported a rise in first-quarter profit on Tuesday, driven by strong sales growth in ...
AstraZeneca may face a fine of up to $8 million in China over suspected unpaid taxes related to the import of its breast ...
AstraZeneca on Tuesday said it may face a fine of up to $8 million over suspected unpaid import taxes in China as the ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
European stocks finished on a mixed note on Tuesday, as markets continued to claw their way back to levels seen before Donald Trump's trade tariffs were first announced.
DelveInsight's "FABHALTA Market Size, Forecast, and Market Insight Report" highlights the details around FABHALTA, an oral ...
Richmond American Homes of Florida, LP, a subsidiary of M.D.C. Holdings, Inc., is pleased to announce the Grand Opening of ...
The Middle East isn't just adopting digital transformation?it's engineering the future of banking with bold leadership, smart regulation, and rapid AI investment. It is in this spirit of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results